1063 (1063) Fair Value & Analysis

Industrials · Market cap HK$81.5M

1 1063 1063 · HK

PriceHK$0.0500

Fair ValueHK$0.0650

Upside+30.0%

Quality52/100

Evidence: Medium Range HK$0.0544 – HK$0.0746

Fair value as of: Jul 2, 2026

From 9 valuation models · updated today

Share price −35.9% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.0500 – HK$0.1400 · fair‑value band HK$0.0544 – HK$0.0746 · the HK$0.0500 price screens below the HK$0.0650 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1063 (1063) currently trades at HK$0.0500, while our model-based Fair Value estimate is HK$0.0650 — implying the stock looks roughly 30.0% undervalued today. We read business quality at 52/100 (solid quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Over the trailing twelve months, 1063 generated revenue of HK$50.3M at a net margin of 60.3%. Revenue grew 15.9% year over year. It earns a return on equity of 14.2%. The balance sheet holds a net cash position of HK$9.3M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$50.3M

Revenue growth (YoY) +15.9%

Net margin 60.3%

Return on equity 14.2%

Free cash flow −HK$18.4M FY2025

P/E ratio 2.7

More key figures

Operating margin -106%

EPS (TTM) HK$0.0100

Net cash HK$9.3M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1063 reported revenue of HK$50.3M in FY2025 versus HK$200M in FY2021, a compound −29.2%/yr. Reported net income was HK$30.3M in FY2025.

Revenue −29.2%/yr

FY21 HK$200M

FY22 HK$128M

FY23 HK$66.3M

FY24 HK$38.9M

FY25 HK$50.3M

Net income

FY21 −HK$58.8M

FY22 −HK$57.0M

FY23 HK$40.1M

FY24 −HK$45.4M

FY25 HK$30.3M

Is 1063 fairly valued? → Check now

Similar stocks

6 more Conglomerates stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Honeywell International Inc HON	C$25.91	C$8.49	-67%
Hitachi, Ltd HTHIY	$30.11	$31.31	+4%
CITIC Limited 0267	HK$13.62	HK$22.20	+63%
0019 0019	HK$81.70	HK$13.77	-83%
CK Hutchison Holdings 0001	HK$66.25	HK$118.82	+79%
SK Inc 034730	625,000 KRW	390,279 KRW	-38%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1063 (1063) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.0650 versus a price of HK$0.0500 — about +30% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 1063?

Our model-based fair value for 1063 is HK$0.0650 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.0500.

What is the quality score of 1063?

1063 has a Quality Score of 52/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1063 (1063)?

1063 reported trailing-twelve-month revenue of about HK$50.3M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1063?

The net profit margin of 1063 is about 60.3%, meaning it keeps roughly 60.3% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.